Drug Type Small molecule drug |
Synonyms Sennaquin, 센나퀸정 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (06 Nov 2024), |
Regulation- |
Molecular FormulaC20H38O7S |
InChIKeyHNSDLXPSAYFUHK-UHFFFAOYSA-N |
CAS Registry10041-19-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Constipation | KR | 06 Nov 2024 |